Neosalus Cream
- Generic Name: neosalus hydrating topical cream
- Brand Name: Neosalus Cream
- Drug Class: Emollients
Patient Information
Directions For Use
Apply to affected area three times a day unless otherwise directed by a prescribing healthcare practitioner. NEOSALUS FOAM should be rubbed gently into the skin until it is completely absorbed.
Follow these important directions to ensure proper foaming and maximum delivery of product:
- Shake canister vigorously before each use.
- Turn upside down (nozzle down) to dispense.
- Depress ridged portion of dispenser, as illustrated at right.
Description
NEOSALUS CREAM is a fragrance-free, non-comedogenic water soluble dressing formulated for the management of various types of dermatoses, including atopic dermatitis and allergic contact dermatitis.
Ingredients
Carbomer, dimethicone, ethylparaben, glycerin, methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, sodium hydroxide, stearic acid, trolamine.
Indications
NEOSALUS FOAM is indicated for management and relief of irritation experienced with various types of dermatoses, including atopic dermatitis and allergic contact dermatitis.
Dosage And Administration
Directions For Use
Apply to affected area three times a day unless otherwise directed by a prescribing healthcare practitioner. NEOSALUS FOAM should be rubbed gently into the skin until it is completely absorbed.
Follow these important directions to ensure proper foaming and maximum delivery of product:
- Shake canister vigorously before each use.
- Turn upside down (nozzle down) to dispense.
- Depress ridged portion of dispenser, as illustrated at right.
 |
How Supplied
NEOSALUS FOAM is supplied in a 200 gram aerosolized canister bearing the NDC Number 23710-000-02, a 70 gram aerosolized canister bearing the NDC Number 23710-000-70, and a 10 gram aerosolized canister bearing the NDC Number 23710-000-01.
Store at controlled room temperature 15° to 25°C (59° to 77°F).
Contains flammable materials. Contents under pressure. Do not puncture and/or incinerate the containers. Do not expose to temperatures over 120°F (48°C) even when empty
Manufactured for : Quinnova Pharmaceuticals LLC., Jamison, PA 18929 (877) 660-6263. Revised: Jan 2013
Side Effects
No information provided.
Drug Interactions
No information provided.
Warnings
No information provided.
Precautions
NEOSALUS FOAM is to be used only as directed by a healthcare practitioner. It should not be used to treat any condition other than that for which it is prescribed. For external use only. Avoid contact with the eyes, lips, and other mucous membranes. Exposure of the eye to NEOSALUS FOAM may result in reactions such as stinging and ocular irritation.
If a reaction to NEOSALUS FOAM suggesting sensitivity or chemical irritation occurs, use of the medication should be discontinued and the prescribing healthcare practitioner consulted. This product provides no sunscreen protection. Use of sunscreen products and protective clothing over treated areas is recommended when exposure cannot be avoided.
Certain temporary symptoms such as erythema, dryness, scaling, burning or pruritus may be experienced. These are most likely to occur during the first two to four weeks and will usually lessen with continued use of the medication. Depending upon the severity of the reaction patients should be instructed to reduce the frequency of application or discontinue use and to contact their prescribing healthcare practitioner.
KEEP THIS AND OTHER MEDICATIONS OUT OF THE REACH OF CHILDREN.
Overdose
No information provided.
Contraindications
Known hypersensitivity to any of the NEOSALUS FOAM ingredients.
Clinical Pharmacology
No information provided.